[Symposium] Dyslipidemia

21 Mar 2026 08:30 10:00

101

New Development in Dyslipidemia Management

Time	Session

08:30 09:00	Current and Emerging Therapies for Dyslipidemia Kathryn TanHong Kong, China Speaker Current and Emerging Therapies for Dyslipidemia 101
09:00 09:30	Autologous Implantation of Genetically Modified Adipocytes Expressing LCAT for the Treatment of Familial LCAT Deficiency Koutaro YokoteJapan Speaker Autologous Implantation of Genetically Modified Adipocytes Expressing LCAT for the Treatment of Familial LCAT Deficiency 101
09:30 10:00	Novel and Future Lipid-Lowering Therapy Sung Hee ChoiKorea Speaker Novel and Future Lipid-Lowering Therapy 101